---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-25-000393"
form_type: "8-K"
ticker: "RPRX"
cik: "0001802768"
company_name: "Royalty Pharma plc"
filed_at: "2025-01-10T23:59:59+00:00"
generated_at: "2026-05-28T05:27:23.804536+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Royalty Pharma to acquire external manager for ~$1.1B, announces $3B buyback

## Summary
- Acquires manager RP Management for ~$1.1B: $200M cash, $380M debt assumed, 24.5M RPH shares (4% of shares).
- Cumulative cash savings >$1.6B over ten years; >$100M in 2026 rising to >$175M in 2030.
- Board approves $3B share repurchase; intends $2B in 2025 subject to market conditions.
- Equity consideration vests over 5-9 years; Pablo Legorreta's shares vest in 5 years, others in 9.
- Transaction requires shareholder approval; expected close Q2 2025; ~25% of shares committed to vote in favor.

## SEC filing metadata
- accession: 0000950103-25-000393
- form_type: 8-K
- ticker: RPRX
- cik: 0001802768
- company_name: Royalty Pharma plc
- filed_at: 2025-01-10T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802768/000095010325000393/0000950103-25-000393-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802768/000095010325000393/dp223331_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-25-000393
- JSON: https://secwatch.observer/filing/0000950103-25-000393.json
- Plain text: https://secwatch.observer/filing/0000950103-25-000393.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.